✦ LIBER ✦

A Phase 2, Open-label, Investigator-initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects with Recalcitrant Contact or Atopic Dermatitis

✍ Scribed by Eva Volf; Shiu-Chung Au; Nicole Dumont; Alice Gottlieb

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open label study evaluating the safet

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

An investigator-initiated, open-label st

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Long Term Outcomes of a Phase 1/2, Multi

✍ Christian Hendriksz; Ashok Vellodi; Simon Jones; Hiwot Takkele; S. Lee; Sarah Ch 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

509 The OPAL Study: A Phase II Study to

✍ Jorge Cortes; Eric Feldman; Karen Yee; Martin Toal; Alison Richardson; Anthony C 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 130 KB

WS5.5 A randomised, open label phase 3 s

✍ M. Goldman; A. Schuster; C. Halliburn; G. Döring 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A phase II, randomized, open-label, pilo

✍ M. Aklilu*; A. Hussain; C.P. Evans; R.A. Hannon; A. Lipton; M. Dimairo; J. Yu; P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB